| PERIOD ENDING | 29-Mar-09 | 30-Mar-08 | 31-Mar-07 | | Total Revenue | 115,118 | 89,743 | 68,502 | | Cost of Revenue | 64,873 | 49,631 | 21,968 | | | Gross Profit | 50,245 | 40,112 | 46,534 | | | Operating Expenses | | Research Development | 31,829 | 30,660 | 25,838 | | Selling General and Administrative | 38,962 | 37,899 | 24,925 | | Non Recurring | 59,676 | 173,991 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (80,222) | (202,438) | (4,229) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,904 | 15,446 | 15,569 | | Earnings Before Interest And Taxes | (72,318) | (186,992) | 11,340 | | Interest Expense | 1,253 | 771 |
-
| | Income Before Tax | (73,571) | (187,763) | 11,340 | | Income Tax Expense | (535) | 8,116 | 3,316 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (73,036) | (195,879) | 8,024 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (73,036) | (195,879) | 8,024 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($73,036) | ($195,879) | $8,024 |
|
1.00% Nasdaq 0.00%
Income Statement
